This article is one of six invited review articles published in the Missing the Mark: Hepatic Encephalopathy supplement, which includes CME-accredited articles published in Clinical Gastroenterology and Hepatology (CGH) and the Journal of Hospital Medicine (JHM). The program is administered by AGA in collaboration with the Society of Hospital Medicine. Each article will provide an expert perspective on a topic related to practice gaps in the care and management of patients with cirrhosis and hepatic encephalopathy. This program is commercially supported by Salix.
Faculty
Mohammad Amin Fallahzadeh, MD, MPH
Baylor University Medical Center, Baylor Scott & White Health, Dallas, TX
Robert S. Rahimi, MD, MSCR
Baylor University Medical Center, Baylor Scott & White Health, Dallas, TX
Learning objectives
- Upon completion of this CME exam, successful learners will be able to identify established and novel treatment modalities for hepatic encephalopathy.
Released: June 11, 2022
Expires: May 31, 2026
Disclosures
Mohammad Amin Fallahzadeh, journal author,
does not have any conflict of interest.
Robert S Rahimi, journal author,
served on advisory boards for Mallinckrodt, and has received research support from Valeant and Mallinckrodt (formerly Ocera Therapeutics).
All relevant financial disclosures have been mitigated.
Accreditation and designation statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: May 31, 2026
